Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:SURF

Surface Oncology (SURF) Stock Price, News & Analysis

Surface Oncology logo

About Surface Oncology Stock (NASDAQ:SURF)

Advanced Chart

Key Stats

Today's Range
$1.07
$1.07
50-Day Range
$0.88
$1.08
52-Week Range
$0.56
$1.43
Volume
N/A
Average Volume
430,375 shs
Market Capitalization
$65.08 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive SURF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Surface Oncology and its competitors with MarketBeat's FREE daily newsletter.

SURF Stock News Headlines

I was wrong about Trump
I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.
Q3 2024 Heron Therapeutics Inc Earnings Call
See More Headlines

SURF Stock Analysis - Frequently Asked Questions

Surface Oncology, Inc. (NASDAQ:SURF) released its quarterly earnings data on Thursday, November, 4th. The company reported ($0.44) EPS for the quarter, missing the consensus estimate of ($0.40) by $0.04. The business had revenue of $0.39 million for the quarter.

Surface Oncology (SURF) raised $84 million in an initial public offering on Thursday, April 19th 2018. The company issued 6,000,000 shares at a price of $13.00-$15.00 per share. Goldman Sachs, Cowen and Evercore ISI acted as the underwriters for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Surface Oncology investors own include Meta Platforms (META), NVIDIA (NVDA), CrowdStrike (CRWD), NIO (NIO), Zoom Communications (ZM), QUALCOMM (QCOM) and Workhorse Group (WKHS).

Company Calendar

Last Earnings
11/04/2021
Today
7/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
NASDAQ:SURF
CIK
1718108
Fax
N/A
Employees
35
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($1.53)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$63.59 million
Net Margins
N/A
Pretax Margin
-211.95%
Return on Equity
-107.81%
Return on Assets
-65.57%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
3.60
Quick Ratio
3.60

Sales & Book Value

Annual Sales
$30 million
Price / Sales
2.17
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.81 per share
Price / Book
1.32

Miscellaneous

Outstanding Shares
60,824,000
Free Float
53,525,000
Market Cap
$65.08 million
Optionable
Not Optionable
Beta
1.75
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:SURF) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners